...
首页> 外文期刊>Nature immunology >Universal influenza virus vaccines: Need for clinical trials
【24h】

Universal influenza virus vaccines: Need for clinical trials

机译:通用流感病毒疫苗:需要临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

Vaccines are currently the best counter-measure against influenza virus infections in humans. However, available vaccines are limited in breadth such that they are effective against only the circulating strains that are closely related to the vaccine strain. The genetic variation of influenza viruses allows them to escape immune responses quickly, a mechanism called antigenic drift. Therefore, influenza vaccination programs require annual revaccination with reformulated vaccines-a cumbersome and expensive undertaking. Because vaccine strain selection is based on surveillance and prediction, mismatches between vaccine strains and circulating viruses occur, resulting in a sharp drop of vaccine efficacy.
机译:疫苗是目前针对人类流感病毒感染的最佳对策。然而,可用疫苗的广度受到限制,使得它们仅对与该疫苗株密切相关的循环株有效。流感病毒的遗传变异使它们能够快速逃避免疫反应,这种机制称为抗原漂移。因此,流感疫苗接种计划需要每年重新配制的疫苗,这既繁琐又昂贵。由于疫苗株的选择基于监视和预测,因此会在疫苗株和正在传播的病毒之间发生不匹配,从而导致疫苗效力急剧下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号